Recently, a weighted gene co-expression network analysis (WGCNA) study suggests that PYGL protein can be used as the prognostic biomarker for the survival of pancreatic ductal adenocarcinoma (11). This evidence concerns the gene PYGL and pancreatic ductal adenocarcinoma.